TY - JOUR
T1 - Coronavirus disease 2019 catheterization laboratory survey
AU - Banerjee, Subhash
AU - Tarantini, Giuseppe
AU - Abu-Fadel, Mazen
AU - Banerjee, Avantika
AU - Little, Bertis B.
AU - Sorajja, Paul
AU - Shishehbor, Mehdi H.
AU - Brilakis, Emmanouil S.
N1 - Funding Information:
Dr Banerjee received consulting honoraria from Astra Zeneca, Livmor, American Heart Association (Deputy Editor, Circulation Cardiovascular Interventions), and Cardiovascular Innovations Foundation (Board of Directors). He received institutional research grants from Boston Scientific Corporation and Chiesi. Dr Sorajja received consulting honoraria from Abbott Structural, Medtronic, Boston Scientific Corporation, Edwards Lifesciences, Admedus, W.L. Gore, and Cardiovascular Innovations Foundation (Board of Directors). He received institutional research grants from Abbott Structural, Medtronic, and Boston Scientific Corporation. Dr Shishehbor is an advisory board member and consultant for Abbott Vascular, Medtronic, Boston Scientific Corporation, Terumo, Philips, and Cardiovascular Innovations Foundation (Board of Directors). Dr Brilakis received consulting and speaker honoraria from Abbott Vascular, American Heart Association (Associate Editor, Circulation), Biotronik, Boston Scientific, Cardiovascular Innovations Foundation (Board of Directors), CSI, Elsevier, GE Healthcare, InfraRedx, Medtronic, Siemens, and Teleflex. He received research support from Regeneron and Siemens. He is a shareholder of Minneapolis Heart Institute Ventures. The remaining authors have no disclosures to report.
Publisher Copyright:
© 2020 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.
PY - 2020/8/4
Y1 - 2020/8/4
N2 - BACKGROUND: The coronavirus disease 2019 pandemic is expected to affect operations and lifestyles of interventional cardiologists around the world in unprecedented ways. Timely gathering of information on this topic can provide valuable insight and improve the handling of the ongoing and future pandemic outbreaks. METHODS AND RESULTS: A survey instrument developed by the authors was disseminated via e-mail, text messaging, WhatsApp, and social media to interventional cardiologists between April 6, 2020, and April 11, 2020. A total of 509 responses were collected from 18 countries, mainly from the United States (51%) and Italy (36%). Operators reported significant decline in coronary, structural heart, and endovascular procedure volumes. Personal protective equipment was available to 95% of respondents; however FIT-tested N95 or equivalent masks were available to only 70%, and 74% indicated absence of coronavirus disease 2019 pretesting. Most (83%) operators expressed concern when asked to perform cardiac catheterization on a suspected or confirmed coronavirus disease 2019 patient, primarily because of fear of viral transmission (88%). Although the survey demonstrated significant compliance with social distancing, high use of telemedicine (69%), and online education platforms (80%), there was concern over impending financial loss. CONCLUSIONS: Our survey indicates significant reduction in invasive procedure volumes and concern for viral transmission. There is near universal adoption of personal protective equipment; however, coronavirus disease 2019 pretesting and access to FIT-tested N95 masks is suboptimal. Although there is concern over impending financial loss, substantial engagement in telemedicine and online education is reported.
AB - BACKGROUND: The coronavirus disease 2019 pandemic is expected to affect operations and lifestyles of interventional cardiologists around the world in unprecedented ways. Timely gathering of information on this topic can provide valuable insight and improve the handling of the ongoing and future pandemic outbreaks. METHODS AND RESULTS: A survey instrument developed by the authors was disseminated via e-mail, text messaging, WhatsApp, and social media to interventional cardiologists between April 6, 2020, and April 11, 2020. A total of 509 responses were collected from 18 countries, mainly from the United States (51%) and Italy (36%). Operators reported significant decline in coronary, structural heart, and endovascular procedure volumes. Personal protective equipment was available to 95% of respondents; however FIT-tested N95 or equivalent masks were available to only 70%, and 74% indicated absence of coronavirus disease 2019 pretesting. Most (83%) operators expressed concern when asked to perform cardiac catheterization on a suspected or confirmed coronavirus disease 2019 patient, primarily because of fear of viral transmission (88%). Although the survey demonstrated significant compliance with social distancing, high use of telemedicine (69%), and online education platforms (80%), there was concern over impending financial loss. CONCLUSIONS: Our survey indicates significant reduction in invasive procedure volumes and concern for viral transmission. There is near universal adoption of personal protective equipment; however, coronavirus disease 2019 pretesting and access to FIT-tested N95 masks is suboptimal. Although there is concern over impending financial loss, substantial engagement in telemedicine and online education is reported.
KW - COVID-19
KW - Catheterization laboratory
KW - Coronavirus disease 2019
KW - Survey
UR - http://www.scopus.com/inward/record.url?scp=85089162919&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85089162919&partnerID=8YFLogxK
U2 - 10.1161/JAHA.120.017175
DO - 10.1161/JAHA.120.017175
M3 - Article
C2 - 32515254
AN - SCOPUS:85089162919
SN - 2047-9980
VL - 9
JO - Journal of the American Heart Association
JF - Journal of the American Heart Association
IS - 15
M1 - e017175
ER -